Skip to main content
. 2013 Mar 21;4(4):304–314. doi: 10.7150/jca.4192

Table 3.

Median Time from Diagnosis to Development of CRPC.

Age (y) Group A < 55 Group B 55 - 64 Group C 65 - 74 Group D ≥ 75
Med. Time (y) from Dx to CRPC (95% CI)† 2.1 (1.5-2.9) 2.8(1.8-3.7) 3.4(2.7-4.5) 1.3(0.9-1.9)
5-Year CRPC-free Survival (%) (95% CI) 17 (6-32) 32 (23-40) 40 (32-48) 3(0.2-13)

Abbreviations: Dx, diagnosis;y, years; CRPC, castration resistant prostate cancer; m, months, († depicts log rank test statistical significance p<0.0001).